Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis

Blood. 2001 Sep 1;98(5):1532-41. doi: 10.1182/blood.v98.5.1532.

Abstract

The phenotype of Bcr-Abl-transformed cells is characterized by a growth factor-independent survival and a reduced susceptibility to apoptosis. Furthermore, Bcr-Abl kinase alters adhesion features by phosphorylating cytoskeletal and/or signaling proteins important for integrin function. Integrin-mediated adhesion to extracellular matrix molecules is critical for the regulation of growth and apoptosis. However, effects of integrin signaling on regulation of apoptosis in cells expressing Bcr-Abl are largely unknown. The influence of adhesion on survival and apoptosis in Bcr-Abl+ and Bcr-Abl- BaF3 cells was investigated. p185bcr-abl-transfected BaF3 cells preadhered to immobilized fibronectin had a significant survival advantage and reduced susceptibility to apoptosis following gamma-irradiation when compared with the same cells grown on laminin, on polylysin, or in suspension. Both inhibition of Bcr-Abl kinase by STI571 and inhibition of specific adhesion reversed the fibronectin-mediated antiapoptotic effect in BaF3p185. The DNA damage response of Bcr-Abl- BaF3 cells was not affected by adhesion to fibronectin. In contrast to parental BaF3 cells, BaF3p185 adherent to fibronectin did not release cytochrome c to the cytosol following irradiation. The fibronectin-mediated antiapoptotic mechanism in Bcr-Abl-active cells was not mediated by overexpression of Bcl-XL or Bcl-2 but required an active phosphatidylinositol 3-kinase (PI-3K). Kinase-active Bcr-Abl in combination with fibronectin-induced integrin signaling led to a hyperphosphorylation of AKT. Thus, cooperative activation of PI-3K/AKT by Bcr-Abl and integrins causes synergistic protection of Bcr-Abl+ cells from DNA damage-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Apoptosis / radiation effects
  • Benzamides
  • Cell Adhesion / physiology*
  • Cell Cycle
  • Cell Division / drug effects
  • Cell Line
  • Cell Line, Transformed
  • DNA / radiation effects
  • DNA Damage*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Fibronectins / chemistry*
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / physiology*
  • Gamma Rays
  • Gene Expression Regulation
  • Imatinib Mesylate
  • In Situ Nick-End Labeling
  • Integrins / antagonists & inhibitors
  • Integrins / metabolism
  • Interleukin-3 / pharmacology
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Lymphocytes / radiation effects
  • Mice
  • Microscopy, Confocal
  • Mitochondria / enzymology
  • Piperazines / pharmacology
  • Protein Serine-Threonine Kinases*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Pyrimidines / pharmacology
  • Recombinant Fusion Proteins / antagonists & inhibitors
  • Recombinant Fusion Proteins / physiology
  • Transfection
  • bcl-X Protein

Substances

  • Bcl2l1 protein, mouse
  • Benzamides
  • Enzyme Inhibitors
  • Fibronectins
  • Integrins
  • Interleukin-3
  • Piperazines
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Pyrimidines
  • Recombinant Fusion Proteins
  • bcl-X Protein
  • Imatinib Mesylate
  • DNA
  • Fusion Proteins, bcr-abl
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt